Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to <i>Pro Re Nata</i> or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane

<div>Number of injections and visits according to treatment regimen at 12 months. PRN, <i>pro re nata</i> regimen; TER, treat-and-extend regimen. Error bars represent standard deviation.</div>

Journal of Ophthalmology

fig1

Figure 1

Figure 1: Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to <i>Pro Re Nata</i> or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane 

Figure 1 | Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to Pro Re Nata or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane 